Contents of this document
- Improved product mix and lower silicon wafer production costs¥250 million
- Higher labor, raw material and depreciation costs, among others¥-180 million
- Higher research and development and selling, general and administrative expenses, including depreciation and personnel expenses¥-160 million
- Lower trial sales of products under development and changes in the timing of shareholder benefit expenses¥-100 million
- Renovation of the PET beverage production line, under way from April through December
- Initiatives aimed at improving costs from the second quarter onward through negotiations for appropriate pricing and other measures
- ChemicalsNet Sales¥5,408 millionYear-on-year change in revenue+1.9%Operating profit¥203 millionYear-on-year operating profit growth-52.8%
- BottlingNet Sales¥664 millionYear-on-year change in revenue-28.6%Operating profit¥-367 millionYear-on-year operating profit growth-21.9%
- Metal ProcessingNet Sales¥1,901 millionYear-on-year change in revenue+1.7%Operating profit¥176 millionYear-on-year operating profit growth+2.3%
- Engineering SNet Sales¥1,036 millionYear-on-year change in revenue-13.6%Operating profit¥205 millionYear-on-year operating profit growth+29.1%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥8,654 million (YoY -0.0%) |
| Operating profit | ¥255 million (YoY -42.7%) |
| Ordinary income | ¥385 million (YoY -33.7%) |
| Net income | ¥68 million (YoY -77.0%) |
| Selling, general and administrative expenses | ¥1,728 million |
| Results for the three months of the current quarter | Net Sales ¥8,654 million / Operating profit ¥255 million / Ordinary income ¥385 million / Net income ¥68 million |
| Full-year earnings forecast | Net Sales ¥37,200 million / Operating profit ¥3,200 million / Ordinary income ¥3,300 million / Net income ¥3,000 million / Year-end dividend 42 Yen/share |
| Progress against full-year forecast | Consolidated revenue 23.2% / Consolidated operating profit 7.9% / Chemicals revenue 22.5% / Chemicals operating profit 9.6% / Bottling net sales 18.4% / Bottling operating income Not disclosed / Metal Processing net sales 25.6% / Metal Processing operating income 28.3% / Engineering S net sales 17.8% / Engineering S operating income 31.5% / Total net sales of reported business segments 22.0% / Total operating income of reported business segments 6.4% |
| Self-assessment against the plan | Consolidated results are progressing as planned |
| Segment results | Segment Chemicals / Net Sales ¥5,408 million / Year-on-year change in revenue +1.9% / Operating profit ¥203 million / Year-on-year operating profit growth -52.8%, Segment Bottling / Net Sales ¥664 million / Year-on-year change in revenue -28.6% / Operating profit ¥-367 million / Year-on-year operating profit growth -21.9%, Segment Metal Processing / Net Sales ¥1,901 million / Year-on-year change in revenue +1.7% / Operating profit ¥176 million / Year-on-year operating profit growth +2.3%, Segment Engineering S / Net Sales ¥1,036 million / Year-on-year change in revenue -13.6% / Operating profit ¥205 million / Year-on-year operating profit growth +29.1% |
| Breakdown of Factors Affecting the Change | Factors Improved product mix and lower silicon wafer production costs / Amount ¥250 million, Factors Higher labor, raw material and depreciation costs, among others / Amount ¥-180 million, Factors Higher research and development and selling, general and administrative expenses, including depreciation and personnel expenses / Amount ¥-160 million, Factors Lower trial sales of products under development and changes in the timing of shareholder benefit expenses / Amount ¥-100 million |
| Annual Dividend | 42 Yen/share |
| New initiatives | Renovation of the PET beverage production line, under way from April through December, Initiatives aimed at improving costs from the second quarter onward through negotiations for appropriate pricing and other measures |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating income benefited from a ¥250 million increase due to an improved product mix and lower silicon wafer production costs. However, it was adversely affected by ¥180 million in higher labor, raw material and depreciation costs, ¥160 million in higher research and development and selling, general and administrative expenses, and ¥100 million from lower trial sales of products under development and changes in the timing of shareholder benefit expenses. The decrease in net income was attributed to higher income taxes due to the sale of a subsidiary and other factors.